Publication | Closed Access
Ivacaftor improves rhinologic, psychologic, and sleep‐related quality of life in G551D cystic fibrosis patients
66
Citations
32
References
2018
Year
Ivacaftor improves QOL in the R, P, and S domains in G551D CF patients, although QOL instruments validated for CRS may not translate well to CF CRS patients because symptom burden was surprisingly low.
| Year | Citations | |
|---|---|---|
Page 1
Page 1